179 related articles for article (PubMed ID: 17005833)
1. Efficacy of ambruticin analogs in a murine model of invasive pulmonary aspergillosis.
Chiang LY; Ejzykowicz DE; Tian ZQ; Katz L; Filler SG
Antimicrob Agents Chemother; 2006 Oct; 50(10):3464-6. PubMed ID: 17005833
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of ambruticin analogs in a murine model of coccidioidomycosis.
Shubitz LF; Galgiani JN; Tian ZQ; Zhong Z; Timmermans P; Katz L
Antimicrob Agents Chemother; 2006 Oct; 50(10):3467-9. PubMed ID: 17005834
[TBL] [Abstract][Full Text] [Related]
3. Standardization of an experimental murine model of invasive pulmonary aspergillosis.
Sheppard DC; Graybill JR; Najvar LK; Chiang LY; Doedt T; Kirkpatrick WR; Bocanegra R; Vallor AC; Patterson TF; Filler SG
Antimicrob Agents Chemother; 2006 Oct; 50(10):3501-3. PubMed ID: 17005844
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of SCH51048 in an experimental model of pulmonary aspergillosis.
Allendoerfer R; Loebenberg D; Rinaldi MG; Graybill JR
Antimicrob Agents Chemother; 1995 Jun; 39(6):1345-8. PubMed ID: 7574528
[TBL] [Abstract][Full Text] [Related]
5. Comparative study on the efficacy of AmBisome and Fungizone in a mouse model of pulmonary aspergillosis.
Takemoto K; Yamamoto Y; Ueda Y; Sumita Y; Yoshida K; Niki Y
J Antimicrob Chemother; 2006 Apr; 57(4):724-31. PubMed ID: 16446374
[TBL] [Abstract][Full Text] [Related]
6. Assessment of serum (1->3)-beta-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosis.
Wiederhold NP; Najvar LK; Vallor AC; Kirkpatrick WR; Bocanegra R; Molina D; Olivo M; Graybill JR; Patterson TF
Antimicrob Agents Chemother; 2008 Mar; 52(3):1176-8. PubMed ID: 18160526
[TBL] [Abstract][Full Text] [Related]
7. Proangiogenic growth factors potentiate in situ angiogenesis and enhance antifungal drug activity in murine invasive aspergillosis.
Ben-Ami R; Albert ND; Lewis RE; Kontoyiannis DP
J Infect Dis; 2013 Apr; 207(7):1066-74. PubMed ID: 23303813
[TBL] [Abstract][Full Text] [Related]
8. Caspofungin: antifungal activity in vitro, pharmacokinetics, and effects on fungal load and animal survival in neutropenic rats with invasive pulmonary aspergillosis.
van Vianen W; de Marie S; ten Kate MT; Mathot RA; Bakker-Woudenberg IA
J Antimicrob Chemother; 2006 Apr; 57(4):732-40. PubMed ID: 16464895
[TBL] [Abstract][Full Text] [Related]
9. Caspofungin prolongs survival of transiently neutropenic rats with advanced-stage invasive pulmonary aspergillosis.
van de Sande WW; van Vianen W; ten Kate MT; Vissers J; Laurijsens J; Tavakol M; Rijnders BJ; Mathot RA; Bakker-Woudenberg IA
Antimicrob Agents Chemother; 2008 Apr; 52(4):1345-50. PubMed ID: 18195059
[TBL] [Abstract][Full Text] [Related]
10. In vivo resistance of a laboratory-selected Aspergillus fumigatus isolate to amphotericin B.
Manavathu EK; Cutright JL; Chandrasekar PH
Antimicrob Agents Chemother; 2005 Jan; 49(1):428-30. PubMed ID: 15616327
[TBL] [Abstract][Full Text] [Related]
11. Aerosolized nanostructured itraconazole as prophylaxis against invasive pulmonary aspergillosis.
Alvarez CA; Wiederhold NP; McConville JT; Peters JI; Najvar LK; Graybill JR; Coalson JJ; Talbert RL; Burgess DS; Bocanegra R; Johnston KP; Williams RO
J Infect; 2007 Jul; 55(1):68-74. PubMed ID: 17360039
[TBL] [Abstract][Full Text] [Related]
12. Efficient clearance of Aspergillus fumigatus in murine lungs by an ultrashort antimicrobial lipopeptide, palmitoyl-lys-ala-DAla-lys.
Vallon-Eberhard A; Makovitzki A; Beauvais A; Latgé JP; Jung S; Shai Y
Antimicrob Agents Chemother; 2008 Sep; 52(9):3118-26. PubMed ID: 18606837
[TBL] [Abstract][Full Text] [Related]
13. Antifungal prophylaxis is effective against murine invasive pulmonary aspergillosis.
Rieg G; Spellberg B; Schwartz J; Fu Y; Edwards JE; Sheppard DC; Ibrahim AS
Antimicrob Agents Chemother; 2006 Aug; 50(8):2895-6. PubMed ID: 16870798
[No Abstract] [Full Text] [Related]
14. Efficacy of FK463, a new lipopeptide antifungal agent, in mouse models of pulmonary aspergillosis.
Matsumoto S; Wakai Y; Nakai T; Hatano K; Ushitani T; Ikeda F; Tawara S; Goto T; Matsumoto F; Kuwahara S
Antimicrob Agents Chemother; 2000 Mar; 44(3):619-21. PubMed ID: 10681328
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis.
Chandrasekar PH; Cutright JL; Manavathu EK
Clin Microbiol Infect; 2004 Oct; 10(10):925-8. PubMed ID: 15373889
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of nebulized liposomal amphotericin B in treatment of experimental pulmonary aspergillosis.
Gavaldà J; Martín MT; López P; Gomis X; Ramírez JL; Rodríguez D; Len O; Puigfel Y; Ruíz I; Pahissa A
Antimicrob Agents Chemother; 2005 Jul; 49(7):3028-30. PubMed ID: 15980392
[TBL] [Abstract][Full Text] [Related]
17. A murine model of invasive aspergillosis: variable benefit of interferon-gamma administration under in vitro and in vivo conditions.
Johnson CP; Edmiston CE; Zhu YR; Adams MB; Roza AM; Kurup V
Surg Infect (Larchmt); 2005; 6(4):397-407. PubMed ID: 16433604
[TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance in Aspergillus fumigatus.
Warris A; Weemaes CM; Verweij PE
N Engl J Med; 2002 Dec; 347(26):2173-4. PubMed ID: 12501236
[No Abstract] [Full Text] [Related]
19. Pulmonary aspergillosis in mice: treatment with a new triazole SCH39304.
Defaveri J; Salazar MH; Rinaldi MG; Graybill JR
Am Rev Respir Dis; 1990 Sep; 142(3):512-5. PubMed ID: 2202244
[TBL] [Abstract][Full Text] [Related]
20. [Case of pulmonary aspergillosis successfully treated with itraconazole].
Watanabe T; Kuriyama K; Kamei K
Jpn J Antibiot; 2000 Feb; 53(2):103-6; discussion 106-7. PubMed ID: 10896537
[No Abstract] [Full Text] [Related]
[Next] [New Search]